DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo


145.04 -4.87 (-3.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $145.04 -3.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $148.93
Previous Close $149.91
Daily Range $143.69 - $149.39
52-Week Range $130.09 - $181.81
Market Cap $109.4B
P/E Ratio 14.44
Dividend (Yield) $4.00 (2.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,451,579
Average Daily Volume 3,980,439
Current FY EPS $10.05




Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary Rss Feed

Biogen Inc. Takes Aim at Johnson & Johnson

Biogen's Samsung Bioepis has Remicade in its crosshairs.

Amgen's Blincyto and Repatha Positive in Phase III Studies

Leerink Is Back On Board The Biotech Train

Samsung Bioepis And Biogen: A Profitable Case For SB2 And Enbrel

Will 2016 Be Amgen Inc.'s Best Year Yet?

Amgen garnered a half-dozen drug approvals between December 2014 and the end of 2015, and the company delivered record full-year sales and profits in 2015. Could 2016 prove even better?

Gilead Reports Record Results, Street Remains Bored: Why? What's Next?

Why NantKwest Shares Fell 41% in January

Billionaire Patrick Soon-Shiong hopes to change cancer treatment forever.

Plenty of Opportunity to Buy Individual Stocks: John Buckingham

Noteworthy ETF Outflows: IUSG, AMGN, UNP, RAI

Is The Biotech Sector Bottoming Out?

See More AMGN News...

AMGN's Top Competitors

AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
CELG $97.89 (-3.96%)
Current stock: CELG
$0.00 (0.00%)
Current stock: